Association of tumor necrosis factor receptor type II polymorphism 196R with systemic lupus erythematosus in the Japanese molecular and functional analysis

Chika Morita, Takahiko Horiuchi, Hiroshi Tsukamoto, Nobuaki Hatta, Yuji Kikuchi, Yojiro Arinobu, Takeshi Otsuka, Takuya Sawabe, Shin Ichi Harashima, Kohei Nagasawa, Yoshiyuki Niho

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

Objective. To investigate whether a polymorphism(s) or mutation(s) in the tumor necrosis factor receptor II (TNFRII) gene is involved in the pathogenesis of systemic lupus erythematosus (SLE). Methods. All 10 exons of the TNFRII gene were analyzed by exon-specific polymerase chain reaction-single-strand conformation polymorphism, followed by nucleotide sequencing of exons that displayed aberrant bands. To analyze the function of the TNFRII polymorphisms, the full-length TNFRII complementary DNA of each allele was transfected in HeLa cells and then studied for specific binding of 125I-TNFα, as well as interleukin-6 (IL-6) production and cytotoxic activity after treatment with recombinant human TNFα. Results. We identified 4 polymorphisms, at codons 56, 181, 196, and 232. The latter 2 had amino acid substitutions M196R and E232K, respectively. Only the 196R allele was significantly associated with SLE in our 105 Japanese SLE patients, with an allele frequency of 20.5%, compared with 12.6% in 99 healthy controls (P = 0.0335). More importantly, using TNFRII-transfected HeLa cells, we demonstrated significantly increased IL-6 production by 196R TNFRII compared with 196M TNFRII. The cytotoxic activity induced by 196R TNFRII was also increased compared with that of 196M TNFRII. This increase was achieved without affecting the binding affinity of TNFα to TNFRII, as demonstrated by the finding that specific TNFα binding to the HeLa transfectants of 196R and 196M TNFRII was similar, with Kd values of 3.12 × 10-10M and 4.34 × 10-10M, respectively. Conclusion. These results suggest that 196R TNFRII, which transduces the signals of TNFα more effectively than does 196M TNFRII, is involved in the pathogenesis of SLE.

Original languageEnglish
Pages (from-to)2819-2827
Number of pages9
JournalArthritis and rheumatism
Volume44
Issue number12
DOIs
Publication statusPublished - Dec 1 2001

Fingerprint

Receptors, Tumor Necrosis Factor, Type II
Tumor Necrosis Factor Receptors
Systemic Lupus Erythematosus
Exons
HeLa Cells
Interleukin-6
Alleles
Amino Acid Substitution
Gene Frequency
Codon
Genes

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Pharmacology (medical)

Cite this

Association of tumor necrosis factor receptor type II polymorphism 196R with systemic lupus erythematosus in the Japanese molecular and functional analysis. / Morita, Chika; Horiuchi, Takahiko; Tsukamoto, Hiroshi; Hatta, Nobuaki; Kikuchi, Yuji; Arinobu, Yojiro; Otsuka, Takeshi; Sawabe, Takuya; Harashima, Shin Ichi; Nagasawa, Kohei; Niho, Yoshiyuki.

In: Arthritis and rheumatism, Vol. 44, No. 12, 01.12.2001, p. 2819-2827.

Research output: Contribution to journalArticle

Morita, Chika ; Horiuchi, Takahiko ; Tsukamoto, Hiroshi ; Hatta, Nobuaki ; Kikuchi, Yuji ; Arinobu, Yojiro ; Otsuka, Takeshi ; Sawabe, Takuya ; Harashima, Shin Ichi ; Nagasawa, Kohei ; Niho, Yoshiyuki. / Association of tumor necrosis factor receptor type II polymorphism 196R with systemic lupus erythematosus in the Japanese molecular and functional analysis. In: Arthritis and rheumatism. 2001 ; Vol. 44, No. 12. pp. 2819-2827.
@article{0133c652363e466c9b7e65c97bf1a669,
title = "Association of tumor necrosis factor receptor type II polymorphism 196R with systemic lupus erythematosus in the Japanese molecular and functional analysis",
abstract = "Objective. To investigate whether a polymorphism(s) or mutation(s) in the tumor necrosis factor receptor II (TNFRII) gene is involved in the pathogenesis of systemic lupus erythematosus (SLE). Methods. All 10 exons of the TNFRII gene were analyzed by exon-specific polymerase chain reaction-single-strand conformation polymorphism, followed by nucleotide sequencing of exons that displayed aberrant bands. To analyze the function of the TNFRII polymorphisms, the full-length TNFRII complementary DNA of each allele was transfected in HeLa cells and then studied for specific binding of 125I-TNFα, as well as interleukin-6 (IL-6) production and cytotoxic activity after treatment with recombinant human TNFα. Results. We identified 4 polymorphisms, at codons 56, 181, 196, and 232. The latter 2 had amino acid substitutions M196R and E232K, respectively. Only the 196R allele was significantly associated with SLE in our 105 Japanese SLE patients, with an allele frequency of 20.5{\%}, compared with 12.6{\%} in 99 healthy controls (P = 0.0335). More importantly, using TNFRII-transfected HeLa cells, we demonstrated significantly increased IL-6 production by 196R TNFRII compared with 196M TNFRII. The cytotoxic activity induced by 196R TNFRII was also increased compared with that of 196M TNFRII. This increase was achieved without affecting the binding affinity of TNFα to TNFRII, as demonstrated by the finding that specific TNFα binding to the HeLa transfectants of 196R and 196M TNFRII was similar, with Kd values of 3.12 × 10-10M and 4.34 × 10-10M, respectively. Conclusion. These results suggest that 196R TNFRII, which transduces the signals of TNFα more effectively than does 196M TNFRII, is involved in the pathogenesis of SLE.",
author = "Chika Morita and Takahiko Horiuchi and Hiroshi Tsukamoto and Nobuaki Hatta and Yuji Kikuchi and Yojiro Arinobu and Takeshi Otsuka and Takuya Sawabe and Harashima, {Shin Ichi} and Kohei Nagasawa and Yoshiyuki Niho",
year = "2001",
month = "12",
day = "1",
doi = "10.1002/1529-0131(200112)44:12<2819::AID-ART469>3.0.CO;2-2",
language = "English",
volume = "44",
pages = "2819--2827",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "12",

}

TY - JOUR

T1 - Association of tumor necrosis factor receptor type II polymorphism 196R with systemic lupus erythematosus in the Japanese molecular and functional analysis

AU - Morita, Chika

AU - Horiuchi, Takahiko

AU - Tsukamoto, Hiroshi

AU - Hatta, Nobuaki

AU - Kikuchi, Yuji

AU - Arinobu, Yojiro

AU - Otsuka, Takeshi

AU - Sawabe, Takuya

AU - Harashima, Shin Ichi

AU - Nagasawa, Kohei

AU - Niho, Yoshiyuki

PY - 2001/12/1

Y1 - 2001/12/1

N2 - Objective. To investigate whether a polymorphism(s) or mutation(s) in the tumor necrosis factor receptor II (TNFRII) gene is involved in the pathogenesis of systemic lupus erythematosus (SLE). Methods. All 10 exons of the TNFRII gene were analyzed by exon-specific polymerase chain reaction-single-strand conformation polymorphism, followed by nucleotide sequencing of exons that displayed aberrant bands. To analyze the function of the TNFRII polymorphisms, the full-length TNFRII complementary DNA of each allele was transfected in HeLa cells and then studied for specific binding of 125I-TNFα, as well as interleukin-6 (IL-6) production and cytotoxic activity after treatment with recombinant human TNFα. Results. We identified 4 polymorphisms, at codons 56, 181, 196, and 232. The latter 2 had amino acid substitutions M196R and E232K, respectively. Only the 196R allele was significantly associated with SLE in our 105 Japanese SLE patients, with an allele frequency of 20.5%, compared with 12.6% in 99 healthy controls (P = 0.0335). More importantly, using TNFRII-transfected HeLa cells, we demonstrated significantly increased IL-6 production by 196R TNFRII compared with 196M TNFRII. The cytotoxic activity induced by 196R TNFRII was also increased compared with that of 196M TNFRII. This increase was achieved without affecting the binding affinity of TNFα to TNFRII, as demonstrated by the finding that specific TNFα binding to the HeLa transfectants of 196R and 196M TNFRII was similar, with Kd values of 3.12 × 10-10M and 4.34 × 10-10M, respectively. Conclusion. These results suggest that 196R TNFRII, which transduces the signals of TNFα more effectively than does 196M TNFRII, is involved in the pathogenesis of SLE.

AB - Objective. To investigate whether a polymorphism(s) or mutation(s) in the tumor necrosis factor receptor II (TNFRII) gene is involved in the pathogenesis of systemic lupus erythematosus (SLE). Methods. All 10 exons of the TNFRII gene were analyzed by exon-specific polymerase chain reaction-single-strand conformation polymorphism, followed by nucleotide sequencing of exons that displayed aberrant bands. To analyze the function of the TNFRII polymorphisms, the full-length TNFRII complementary DNA of each allele was transfected in HeLa cells and then studied for specific binding of 125I-TNFα, as well as interleukin-6 (IL-6) production and cytotoxic activity after treatment with recombinant human TNFα. Results. We identified 4 polymorphisms, at codons 56, 181, 196, and 232. The latter 2 had amino acid substitutions M196R and E232K, respectively. Only the 196R allele was significantly associated with SLE in our 105 Japanese SLE patients, with an allele frequency of 20.5%, compared with 12.6% in 99 healthy controls (P = 0.0335). More importantly, using TNFRII-transfected HeLa cells, we demonstrated significantly increased IL-6 production by 196R TNFRII compared with 196M TNFRII. The cytotoxic activity induced by 196R TNFRII was also increased compared with that of 196M TNFRII. This increase was achieved without affecting the binding affinity of TNFα to TNFRII, as demonstrated by the finding that specific TNFα binding to the HeLa transfectants of 196R and 196M TNFRII was similar, with Kd values of 3.12 × 10-10M and 4.34 × 10-10M, respectively. Conclusion. These results suggest that 196R TNFRII, which transduces the signals of TNFα more effectively than does 196M TNFRII, is involved in the pathogenesis of SLE.

UR - http://www.scopus.com/inward/record.url?scp=0035673169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035673169&partnerID=8YFLogxK

U2 - 10.1002/1529-0131(200112)44:12<2819::AID-ART469>3.0.CO;2-2

DO - 10.1002/1529-0131(200112)44:12<2819::AID-ART469>3.0.CO;2-2

M3 - Article

VL - 44

SP - 2819

EP - 2827

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 12

ER -